BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 12, 2009
View Archived Issues
NovImmune Raises $56.5M to Broaden Antibody Pipeline
NovImmune SA secured CHF62.5 million (US$56.5 million) in what may well turn out to be the largest private equity deal completed by a European biotechnology firm this year. (BioWorld Today)
Read More
Biotech's Birthplace Fights to Preserve Innovation, Education
Read More
New Target For Inflammatory Aspects of Heart Disease
Read More
Health Groups Form Pact to Cut Costs by $2 Trillion
Read More
Ardea Restructures to Focus on its Clinical Programs
Read More
After Stock Bump, Hemispherx Bringing in $18.3M Publicly
Read More
Roche Partners with Tekmira to Advance Two RNAi Products
Read More
Other News To Note
Read More
Clinic Roundup
Read More